We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical Correlates and Prognostic Significance of IL-8, sIL-2R, and Immunoglobulin-Free Light Chain Levels in Patients with Myelofibrosis.
- Authors
Barabanshikova, Maria V.; Dubina, Irina A.; Lapin, Sergey V.; Morozova, Elena V.; Vlasova, Julia J.; Ivanova, Maria O.; Moiseev, Ivan S.; Afanasyev, Boris V.
- Abstract
Background: Chronic myeloproliferative neoplasms are characterized by clonal hematopoiesis and persistent inflammatory reaction. In this study, the clinical significance and prognostic impact of several inflammatory markers were evaluated in patients with BCR/ABL-nega- tive myeloproliferative malignancies. Methods: Serum levels of interleukin-8 (IL-8) and lymphoid-associated activation markers - soluble interleukin-2 receptor (sIL-2R) and immunoglobulin-free light chains (FLC) - were evaluated in patients with primary myelofibrosis (MF), postpolycythemia vera MF, and post-essential thrombo- cythemia MF, and compared with the levels in healthy donors. Results: In 57 MF patients, sIL-2R excess correlated with transfusion-dependent anemia (p = 0.03) and splenomegaly (p = 0.02). There were no statistically significant correlations between sIL-2R and IL-8 levels, but the plasma concentration of κ-FLC positively correlated with the IL-8 level (p = 0.027). In univariate analysis, increased levels of IL-8 (p = 0.016) and sIL-2R (p = 0.010) significantly reduced 1-year overall survival. Only elevated sIL-2R rate retained significance (p = 0.02) in multivariate analysis when Dynamic International Prognostic Scoring System plus (DIPSSplus) risk stratification was added. Conclusion: We observed an association between FLC and proinflammatory cytokine hyperexpression. Serum cytokine levels and FLC might be a promising approach to predicting and monitoring treatment response in MF patients.
- Subjects
IMMUNOGLOBULINS; MYELOFIBROSIS; TUMORS; ANEMIA; HEMATOPOIESIS; IMMUNOGLOBULIN light chains
- Publication
Oncology Research & Treatment, 2017, Vol 40, Issue 10, p574
- ISSN
2296-5270
- Publication type
Article
- DOI
10.1159/000477253